Literature DB >> 16945454

Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection.

Fu Shi Quan1, Richard W Compans, Young-Keol Cho, Sang-Moo Kang.   

Abstract

We have investigated the adjuvant roles of common herbal medicines (ginseng, Salviae) and their effects on early immune responses during influenza virus infection in a mouse model. Intranasal co-administration with inactivated influenza virus A (PR8) and ginseng or Salviae extract increased the levels of influenza virus specific antibodies and neutralizing activities compared to immunization with PR8 alone, and provided protective immunity. Salviae co-administration significantly enhanced IFN-gamma and IL-2 cytokine producing splenocytes while ginseng induced high levels of IL-4 and IL-5 cytokine producing cells after challenge infection. Cells expressing an early activation marker CD69 and levels of a pro-inflammatory cytokine IL-6 were highly elevated in lungs from naïve mice during challenge virus infection, which might be a mechanism in lung inflammation leading to death. In contrast, immunized mice that were co-administered ginseng or Salviae modulated CD69 expressing immune cells, did not produce IL-6, and showed significant enhancement of influenza virus specific IgA antibody in lungs after challenge virus infection. Therefore, these results indicate that both ginseng and Salviae play a role as mucosal adjuvants against influenza virus as well as immuno-modulators during influenza virus infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16945454     DOI: 10.1016/j.vaccine.2006.07.041

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  27 in total

1.  Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.

Authors:  Fu-Shi Quan; Chunzi Huang; Richard W Compans; Sang-Moo Kang
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

Review 2.  Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches.

Authors:  Ruth Elena Soria-Guerra; Leticia Moreno-Fierros; Sergio Rosales-Mendoza
Journal:  Plant Cell Rep       Date:  2011-04-20       Impact factor: 4.570

3.  Beneficial effects of a combination of Korean red ginseng and highly active antiretroviral therapy in human immunodeficiency virus type 1-infected patients.

Authors:  Heungsup Sung; You-Sun Jung; Young-Keol Cho
Journal:  Clin Vaccine Immunol       Date:  2009-06-17

4.  Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.

Authors:  Fu-Shi Quan; Yeu-Chun Kim; Jae-Min Song; Hye Suk Hwang; Richard W Compans; Mark R Prausnitz; Sang-Moo Kang
Journal:  Clin Vaccine Immunol       Date:  2013-07-17

5.  Induction of heterosubtypic immunity to influenza virus by intranasal immunization.

Authors:  Fu-Shi Quan; Richard W Compans; Huan H Nguyen; Sang-Moo Kang
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

6.  Protective effect of Korean red ginseng extract on the infections by H1N1 and H3N2 influenza viruses in mice.

Authors:  Dae-Goon Yoo; Min-Chul Kim; Min-Kyung Park; Jae-Min Song; Fu-Shi Quan; Kyoung-Mi Park; Young-Keol Cho; Sang-Moo Kang
Journal:  J Med Food       Date:  2012-08-02       Impact factor: 2.786

7.  Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza.

Authors:  Lisa M Alleva; Charles Cai; Ian A Clark
Journal:  Evid Based Complement Alternat Med       Date:  2009-09-24       Impact factor: 2.629

8.  The world ginseng market and the ginseng (Korea).

Authors:  In-Ho Baeg; Seung-Ho So
Journal:  J Ginseng Res       Date:  2013-03       Impact factor: 6.060

9.  Ginseng, the 'Immunity Boost': The Effects of Panax ginseng on Immune System.

Authors:  Soowon Kang; Hyeyoung Min
Journal:  J Ginseng Res       Date:  2012-10       Impact factor: 6.060

10.  Preventive effect of Korean red ginseng for acute respiratory illness: a randomized and double-blind clinical trial.

Authors:  Chang-Seop Lee; Ju-Hyung Lee; Mira Oh; Kyung-Min Choi; Mi Ran Jeong; Jong-Dae Park; Dae Young Kwon; Ki-Chan Ha; Eun-Ock Park; Nuri Lee; Sun-Young Kim; Eun-Kyung Choi; Min-Gul Kim; Soo-Wan Chae
Journal:  J Korean Med Sci       Date:  2012-12-07       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.